Literature DB >> 24316642

Reply to Rational drug repositioning by medical genetics.

Philippe Sanseau1, Pankaj Agarwal, Michael R Barnes, Tomi Pastinen, J Brent Richards, Lon R Cardon, Vincent Mooser.   

Abstract

Mesh：

Year:  2013        PMID： 24316642     DOI： 10.1038/nbt.2769

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

1.  Use of genome-wide association studies for drug repositioning.

Authors:  Philippe Sanseau; Pankaj Agarwal; Michael R Barnes; Tomi Pastinen; J Brent Richards; Lon R Cardon; Vincent Mooser
Journal:  Nat Biotechnol       Date:  2012-04-10       Impact factor: 54.908

2.  Rational drug repositioning by medical genetics.

Authors:  Zhong-Yi Wang; Hong-Yu Zhang
Journal:  Nat Biotechnol       Date:  2013-12       Impact factor: 54.908

3.  Reengineering translational science: the time is right.

Authors:  Francis S Collins
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

Review 4.  Genetics of osteoporosis from genome-wide association studies: advances and challenges.

Authors:  J Brent Richards; Hou-Feng Zheng; Tim D Spector
Journal:  Nat Rev Genet       Date:  2012-07-18       Impact factor: 53.242

5.  Global patterns of cis variation in human cells revealed by high-density allelic expression analysis.

Authors:  Bing Ge; Dmitry K Pokholok; Tony Kwan; Elin Grundberg; Lisanne Morcos; Dominique J Verlaan; Jennie Le; Vonda Koka; Kevin C L Lam; Vincent Gagné; Joana Dias; Rose Hoberman; Alexandre Montpetit; Marie-Michele Joly; Edward J Harvey; Daniel Sinnett; Patrick Beaulieu; Robert Hamon; Alexandru Graziani; Ken Dewar; Eef Harmsen; Jacek Majewski; Harald H H Göring; Anna K Naumova; Mathieu Blanchette; Kevin L Gunderson; Tomi Pastinen
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

6.  Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing.

Authors:  Yali Xue; Yuan Chen; Qasim Ayub; Ni Huang; Edward V Ball; Matthew Mort; Andrew D Phillips; Katy Shaw; Peter D Stenson; David N Cooper; Chris Tyler-Smith
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

7.  A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.

Authors:  Nabila Bouatia-Naji; Amélie Bonnefond; Christine Cavalcanti-Proença; Thomas Sparsø; Johan Holmkvist; Marion Marchand; Jérôme Delplanque; Stéphane Lobbens; Ghislain Rocheleau; Emmanuelle Durand; Franck De Graeve; Jean-Claude Chèvre; Knut Borch-Johnsen; Anna-Liisa Hartikainen; Aimo Ruokonen; Jean Tichet; Michel Marre; Jacques Weill; Barbara Heude; Maithé Tauber; Katleen Lemaire; Frans Schuit; Paul Elliott; Torben Jørgensen; Guillaume Charpentier; Samy Hadjadj; Stéphane Cauchi; Martine Vaxillaire; Robert Sladek; Sophie Visvikis-Siest; Beverley Balkau; Claire Lévy-Marchal; François Pattou; David Meyre; Alexandra I F Blakemore; Marjo-Riita Jarvelin; Andrew J Walley; Torben Hansen; Christian Dina; Oluf Pedersen; Philippe Froguel
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

8.  Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.

Authors:  Amélie Bonnefond; Nathalie Clément; Katherine Fawcett; Loïc Yengo; Emmanuel Vaillant; Jean-Luc Guillaume; Aurélie Dechaume; Felicity Payne; Ronan Roussel; Sébastien Czernichow; Serge Hercberg; Samy Hadjadj; Beverley Balkau; Michel Marre; Olivier Lantieri; Claudia Langenberg; Nabila Bouatia-Naji; Guillaume Charpentier; Martine Vaxillaire; Ghislain Rocheleau; Nicholas J Wareham; Robert Sladek; Mark I McCarthy; Christian Dina; Inês Barroso; Ralf Jockers; Philippe Froguel
Journal:  Nat Genet       Date:  2012-01-29       Impact factor: 38.330

9.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962
  9 in total
  3 in total

Review 1.  Signature-based approaches for informed drug repurposing: targeting CNS disorders.

Authors:  Rammohan Shukla; Nicholas D Henkel; Khaled Alganem; Abdul-Rizaq Hamoud; James Reigle; Rawan S Alnafisah; Hunter M Eby; Ali S Imami; Justin F Creeden; Scott A Miruzzi; Jaroslaw Meller; Robert E Mccullumsmith
Journal:  Neuropsychopharmacology       Date:  2020-06-30       Impact factor: 8.294

2.  Drug repositioning for diabetes based on 'omics' data mining.

Authors:  Ming Zhang; Heng Luo; Zhengrui Xi; Ekaterina Rogaeva
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

Review 3.  Human genetics as a model for target validation: finding new therapies for diabetes.

Authors:  Soren K Thomsen; Anna L Gloyn
Journal:  Diabetologia       Date:  2017-04-26       Impact factor: 10.122
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.